Wells Fargo downgraded Centessa (CNTA) to Equal Weight from Overweight with a $42 price target after after Eli Lilly (LLY) announced an agreement to acquire the company for $38 per share in cash plus a non-transferable contingent value right worth up to $9 per share.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNTA:
- Centessa downgraded to Hold from Buy at Truist
- Centessa downgraded to Neutral from Buy at Guggenheim
- Disney upgraded, Nike downgraded: Wall Street’s top analyst calls
- Centessa downgraded to Market Perform from Outperform at LifeSci Capital
- Centessa downgraded to Market Perform from Outperform at Leerink